Get started
Author

Shruti Warhadpande

Observed name: S. Warhadpande
ORCID: 0009-0007-1685-6523
Observed ORCID: 0009-0007-1685-6523
OpenAlex ID: A5007780802
Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19
2020 · Michael P. McRae, Glennon W. Simmons, et al. · Lab on a Chip · 106
PDF
FNA biopsy of breast specimens effectively harvests cells for patient‐derived organoids modeling ductal carcinoma in situ
2025 · Julia Ye, Nadine Goldhammer, et al. · Cancer Cytopathology · 2
PDF
Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissue
2026 · Nadine Goldhammer, Marin Bont, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
Biomarker-guided responses in patient-derived organoids predict effective therapies in breast cancer
2026 · Tam Binh V. Bui, Denise M. Wolf, et al. · Cell Reports Medicine
Abstract PS2-12-09: Global expression of small DNA damage-associated RNAs (sdRNAs) in breast cancers
2026 · D. K. DeConti, J. Z. Yu, et al. · Clinical Cancer Research
Culture and Expansion of Circulating Tumor Cells from Breast Malignant Effusions as Organoids
2026 · Amirabbas Parizadeh, Shruti Warhadpande, et al. · Methods in molecular biology
EpiBlot: Joint Mapping of Chromatin Accessibility and Targeted Proteomics in HER2-expressing Breast Cancer Systems
2025 · Anna Fomitcheva Khartchenko, Trinh Lam, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Organoid-evaluable clinical biomarkers predict drug responses and guide new breast cancer therapies
2025 · Tam Binh V. Bui, Denise M. Wolf, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Fine needle aspiration biopsy of breast specimens effectively harvests cells for patient-derived organoids modeling breast ductal carcinoma in situ
2025 · Julia Ye, Nadine Goldhammer, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Abstract 2367: Changes in breast hormone signaling and inflammation underlie radiologic features of cancer risk
2025 · Nadine Goldhammer, Marin Bont, et al. · Cancer Research
Abstract A059: Heterogeneous cell populations in organoid models derived from breast preinvasive and invasive carcinomas after endocrine therapy
2024 · Nadine Goldhammer, Shruti Warhadpande, et al. · Cancer Research
Abstract P3-09-01: Characterization of residual disease after neoadjuvant selective estrogen receptor degrader (SERD) therapy using tumor organoids in the I-SPY Endocrine Optimization Protocol (EOP)
2023 · Jennifer Rosenbluth, Christopher J. Schwartz, et al. · Cancer Research
Works count: 12
Citation count: 108
H-index: 2
I10-index: 1
Year
Topic
Type